Labcyte's ADE technology the preferred technology approach to low volume dispensing (LVD)
with Jonathan Wingfield, Principal Scientist, and Steve Rees, Vice-President of Screening Sciences and Sample Management, AstraZeneca
This year’s Precision Medicine World Conference (PMWC) 2017 in Silicon Valley welcomed 1,300 biotech professionals, 40 sponsoring companies, and 30 exhibitors from around the world and featured presentations by a number of towering figures in the field.
We'd like to congratulate Dr. Patrick Cai and Dr. Krister Wennerberg as among the TOP 10 TEN SLAS Technology papers of 2017!
Labcyte Inc, Sunnyvale, Calif, and Notable Labs, San Francisco, have announced a collaboration to apply Labcyte’s Echo acoustic liquid handling technology to screen individual cancer patients’ tumor cells.
Has precision medicine’s focus on the genome blinded us to vital non-genomic tools? By Joe Olechno, Senior Research Fellow at Labcyte Inc., Sunnyvale, USA
Featured podcast on Mendelspod.com with Dr. Allan Jordan, Head of Chemistry for the Drug Discovery Unit of Cancer Research UK (CRUK)
From smaller-scale assays to industrial-scale screening operations, cell-based assays are critical for applications that include elucidating basic mechanisms of cell function, target validation and compound screening...
Jonathan Wingfield, Principal Scientist at AstraZeneca, describes how acoustic mass spectrometry technology being used to screen biological targets. Filmed at ELRIG Drug Discovery 2016
We’re pleased to report a new application for the Echo Liquid Handler, with plenty of resources available if you’re interested in learning more. Serial microsampling allows scientists to use fewer animals in studies and reduce costs without compromising data quality. This is particularly useful for scientists conducting pharmacokinetics (PK) and pharmacodynamics (PD) research.